Yildiz I - Search Results

1

Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.

Yildiz I, Sen F, Ekenel M, Darendeliler E, Bavbek S, Agaoglu F, Ozger H, Eralp L, Bilgic B, Basaran M. Yildiz I, et al. In Vivo. 2014 May-Jun;28(3):403-9. In Vivo. 2014. PMID: 24815845

2

Response rates and adverse effects of continuous once-daily sunitinib in patients with advanced renal cell carcinoma: a single-center study in Turkey.

Yildiz I, Sen F, Basaran M, Ekenel M, Agaoglu F, Darendeliler E, Tunc HM, Ozcan F, Bavbek S. Yildiz I, et al. Jpn J Clin Oncol. 2011 Dec;41(12):1380-7. doi: 10.1093/jjco/hyr151. Epub 2011 Oct 19. Jpn J Clin Oncol. 2011. PMID: 22013228

3

Optic disc and choroidal metastasis from sporadic medullary thyroid carcinoma: case report and review of the literature.

Yildiz I, Sen F, Tuncer S, Kilic L, Basaran M, Bavbek S. Yildiz I, et al. Onkologie. 2011;34(11):630-3. doi: 10.1159/000334197. Epub 2011 Oct 28. Onkologie. 2011. PMID: 22104161 Review.

4

Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.

Tas F, Keskin S, Karadeniz A, Dağoğlu N, Sen F, Kilic L, Yildiz I. Tas F, et al. Among authors: yildiz i. Oncology. 2011;81(5-6):353-8. doi: 10.1159/000334863. Epub 2012 Jan 13. Oncology. 2011. PMID: 22248874

5

Clinical and prognostic significance of coagulation assays in melanoma.

Tas F, Ciftci R, Kilic L, Bilgin E, Keskin S, Sen F, Yildiz I, Yasasever V. Tas F, et al. Among authors: yildiz i. Melanoma Res. 2012 Oct;22(5):368-75. doi: 10.1097/CMR.0b013e328357be7c. Melanoma Res. 2012. PMID: 22889867

6

Performance status of patients is the major prognostic factor at all stages of pancreatic cancer.

Tas F, Sen F, Odabas H, Kılıc L, Keskın S, Yıldız I. Tas F, et al. Among authors: yildiz i. Int J Clin Oncol. 2013 Oct;18(5):839-46. doi: 10.1007/s10147-012-0474-9. Epub 2012 Sep 21. Int J Clin Oncol. 2013. PMID: 22996141

7

Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC).

Keskin S, Yıldız I, Sen F, Aydogan F, Kilic L, Ekenel M, Saglam S, Sakar B, Disci R, Aykan F. Keskin S, et al. Among authors: yildiz i. Clin Transl Oncol. 2013 May;15(5):403-8. doi: 10.1007/s12094-012-0942-8. Epub 2012 Oct 2. Clin Transl Oncol. 2013. PMID: 23054756

8

Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer.

Tas F, Kilic L, Bilgin E, Keskin S, Sen F, Ciftci R, Yildiz I, Yasasever V. Tas F, et al. Among authors: yildiz i. Int J Gynecol Cancer. 2013 Feb;23(2):276-81. doi: 10.1097/IGC.0b013e31827b8796. Int J Gynecol Cancer. 2013. PMID: 23266651

9

Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.

Aydiner A, Kilic L, Yildiz I, Keskin S, Sen F, Kucucuk S, Karanlik H, Muslumanoglu M, Igci A. Aydiner A, et al. Among authors: yildiz i. Med Oncol. 2013 Mar;30(1):354. doi: 10.1007/s12032-012-0354-1. Epub 2012 Dec 29. Med Oncol. 2013. PMID: 23275115

10

Patterns of complementary and alternative medicine use among Turkish cancer patients.

Yildiz I, Ozguroglu M, Toptas T, Turna H, Sen F, Yildiz M. Yildiz I, et al. Among authors: yildiz m. J Palliat Med. 2013 Apr;16(4):383-90. doi: 10.1089/jpm.2012.0226. Epub 2013 Jan 10. J Palliat Med. 2013. PMID: 23305189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters